A wearable AI assistant designed to support people with early-stage dementia has taken the £1 million Longitude Prize on Dementia.
A £1m Boost for Wearable Tech Tackling Dementia Care
A pair of AI-powered smartglasses developed by a UK-based medtech company, has been named the winner of the Longitude Prize on Dementia.
The award, announced this week, recognises CrossSense“Wispy”, a wearable assistant designed to help people with early-stage dementia manage everyday tasks. For a sector under increasing strain, the result indicates a wider shift towards home care technology that supports independence rather than relying solely on formal services.
Dementia is one of the biggest pressures facing the UK care system. With rising demand and limited workforce capacity across both the NHS and social care, policymakers have increasingly looked to digital health care technology as part of the solution.
What is the Longitude Prize on Dementia?
The Longitude Prize on Dementia launched in 2022, backed by Innovate UK and Challenge Works, as a follow-on to earlier Longitude challenges that focused on issues such as antimicrobial resistance.
It set out to find technology that could learn from people living with dementia, adapt over time, and support them to remain independent.
Unlike many innovation competitions, the prize has placed strong emphasis on real-world usability and measurable impact, reflecting longstanding concerns that promising prototypes in social care often fail to translate into everyday practice.
How the Technology Works in Practice
Wispy is built into a pair of lightweight smartglasses worn throughout the day. Using AI, it can recognise objects, provide prompts, and guide users through routine activities such as making a cup of tea or finding household items.
The system is designed to adapt to each individual, learning habits and preferences over time. This kind of personalisation is increasingly seen as essential in community health technology, particularly for conditions like dementia where needs change gradually.
What sets the approach apart is its attempt to embed support directly into daily life, rather than relying on separate devices or scheduled interventions. For people receiving care at home, that distinction could prove important.
One of the more notable aspects of the project is how it was developed. CrossSense worked with people living with dementia and their carers throughout the process, testing early versions and refining the design based on feedback.
This kind of co-design is becoming more common across social care innovation, but it is still not universal. In dementia care in particular, issues of trust, usability and stigma can limit uptake of new technology.
By involving users from the outset, developers were able to address practical concerns, such as comfort and how the device fits into everyday routines, rather than focusing purely on technical capability.
What it Could Mean for the UK Care Sector
For care providers and commissioners, the appeal of this kind of technology lies in its potential to support people before their needs escalate.
If tools like Wispy can help individuals manage daily tasks and maintain confidence at home, they could reduce reliance on domiciliary care visits or delay the need for more intensive support. That aligns with wider policy goals around prevention and “ageing in place”.
However, adoption is rarely straightforward. The UK care sector has historically been slow to scale new technologies, often due to funding constraints, fragmented procurement, and the need for stronger evidence.
There are also practical questions around how wearable devices would fit into existing care pathways, including integration with NHS systems and local authority services.
From Prize-Winning Idea to Everyday Use
CrossSense says it plans to bring the technology to market within the next year, alongside further studies. That next phase will be critical.
Winning a high-profile prize brings visibility, but it does not guarantee uptake. Demonstrating cost-effectiveness, securing regulatory approval where needed, and ensuring accessibility for a wide range of users will all be key challenges.
For now, the award offers a signal of where innovation in the UK care sector may be heading. Rather than large-scale system overhauls, there is growing focus on relatively small, targeted tools that can make a difference in people’s day-to-day lives.
As demand continues to rise, and with ongoing workforce pressures, such approaches are likely to attract increasing attention from NHS leaders, local authorities and care providers.
Whether they can deliver at scale remains to be seen. But the Longitude Prize result suggests that the search for practical, user-focused solutions in dementia care is beginning to gain ground.
Innovative Care NEWS 
Leave a comment